Pink Sheet is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Sales & Earnings In Brief

This article was originally published in The Tan Sheet

Executive Summary

Chattem expects another "very good year": Chattem prepares to roll out at least six new products in 2009 and is "at a tipping point on moving to the next level," the Chattanooga, Tenn.-based company says. CEO and Chairman Zan Guerry explained during a Jan. 29 fourth-quarter earnings call that the firm has "the best new products line-up, the highest scoring advertising on the biggest promotions kicking off in February through June in history," making 2009 likely another strong year. In fiscal 2008, the firm's total revenues grew 7.4 percent to $454.9 million fueled primarily by the addition of brands acquired from Johnson & Johnson. The company's oral care category advanced 29 percent to $62.9 million and internal OTCs were up 7 percent to $48 million in the September-November period. Chattem's net income grew 11 percent to $66.3 million
Advertisement

Related Content

Arnold Leaves P&G After Reaching Top Of OTC, Personal Care Businesses
Arnold Leaves P&G After Reaching Top Of OTC, Personal Care Businesses
Arnold Leaves P&G After Reaching Top Of OTC, Personal Care Businesses
Matrixx Initiatives Thrives In Cough/Cold, But Eyes Off-Season Relief
Another PPI player
Another PPI player
Matrixx Initiatives Thrives In Cough/Cold, But Eyes Off-Season Relief
NBTY Forced To Hike Prices By Leiner Integration Costs, Shrinking Margins
NBTY Forced To Hike Prices By Leiner Integration Costs, Shrinking Margins
For Nutraceutical International, Growth Is Synonymous With Diversification

Topics

Advertisement
UsernamePublicRestriction

Register

PS102564

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel